Redhill Biopharma Announced The Renewal Of Its Contract With Medi-Cal, California's Medicaid Healthcare Program, To Maintain Talicia's First-line Position On Medi-Cal Fee-For-Service Contract Drug List With No Prior Authorization And A $0 Copay,...
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.